Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 353 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. New version filed on ClinicalTrials.gov
  3. 47 versions Re-verified since Feb 20, 2025, no change to tracked fieldsv305-v351
  4. Minor Trial status: Recruiting to Completed
    • Enrollment target: estimated 3420 to confirmed 3273
    v304
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to use brain imaging technology to compare differences in brain structure, chemistry, and functioning in individuals with brain and mental disorders compared to healthy volunteers. Schizophrenia is a brain disorder that results from subtle changes and abnormalities in neurons. These deficits likely occur in localized regions of the brain and may result in widespread, devastating consequences. The neuronal abnormalities are inherited through a complex combination of genetic and environmental factors. Brain imaging technologies can be used to better characterize brain changes in individuals with schizophrenia. This study will use magnetic resonance imaging (MRI) scans to identify predictable, quantifiable abnormalities in neurophysiology, neurochemistry and neuroanatomy that characterize schizophrenia and other neurological and neuropsychiatric disorders.
Trial Details
NCT Number NCT00004571
Lead Sponsor National Institute of Mental Health (NIMH)
Conditions
(from sponsor)
Schizophrenia, Normal Physiology
Related terms Schizophrenia
Enrollment 3,273 participants
Start Date
Updated on ClinicalTrials.gov